Issie Kirby
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
6
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Issie Kirby
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALC Alcon | Upgrades: Neutral | n/a | $92.17 | - | 1 | Oct 10, 2024 | |
| DXCM DexCom | Initiates: Neutral | $130 | $69.70 | +86.51% | 1 | May 30, 2024 | |
| TNDM Tandem Diabetes Care | Initiates: Buy | $60 | $32.85 | +82.65% | 1 | May 30, 2024 | |
| PODD Insulet | Initiates: Buy | $235 | $237.44 | -1.03% | 1 | May 30, 2024 | |
| COO The Cooper Companies | Upgrades: Buy | $125 | $104.86 | +19.21% | 2 | Mar 19, 2024 |
Alcon
Oct 10, 2024
Upgrades: Neutral
Price Target: n/a
Current: $92.17
Upside: -
DexCom
May 30, 2024
Initiates: Neutral
Price Target: $130
Current: $69.70
Upside: +86.51%
Tandem Diabetes Care
May 30, 2024
Initiates: Buy
Price Target: $60
Current: $32.85
Upside: +82.65%
Insulet
May 30, 2024
Initiates: Buy
Price Target: $235
Current: $237.44
Upside: -1.03%
The Cooper Companies
Mar 19, 2024
Upgrades: Buy
Price Target: $125
Current: $104.86
Upside: +19.21%